Anna Aiello Specialist in Food Science (University of Palermo); European PhD in Molecular Medicine and Biotechnologies (University of Palermo); Master’s degree in Molecular biology (University of Parma)
Researcher under Law 240/10, type B, SSD MED/04 General Pathology, S.C. 06/A2; Assistant Professor of General Pathology., University of Palermo, Palermo, Sicily · Italy
Editorial leadership for Journal of Aging Research And Healthcare ISSN 2474-7785
Research interests
- Inflammaging
- Immunosenescence
- Nutrigerontology
- Bioactive Compounds
Biography
Dr. Anna Aiello, PhD, is a Researcher under Law 240/10, type B, SSD MED/04 General Pathology, S.C. 06/A2, and Assistant Professor of General Pathology at the University of Palermo, Palermo, Sicily, Italy. She received her education from the University of Palermo and the University of Palermo. Her research focuses on inflammaging, immunosenescence, nutrigerontology, and bioactive compounds, with particular emphasis on the biological mechanisms underlying ageing and longevity. Dr. Aiello has authored over 35 indexed publications, including her most-cited work, "The Role of Matrix Metalloproteinases (MMP-2 and MMP-9) in Ageing and Longevity: Focus on Sicilian Long-Living Individuals (LLIs)" (2020), which has been cited 60 times. Her scholarship contributes to understanding the pathological and molecular processes associated with healthy ageing in long-lived populations.
Selected publications
- Nutrigerontology: A key for achieving successful ageing and longevity
- Nutraceutical effects of table green olives: A pilot study with Nocellara del Belice olives
- Mediterranean nutraceutical foods: Strategy to improve vascular ageing
- Nutrient sensing pathways as therapeutic targets for healthy ageing
Considering JARH for your work?
This journal is guided by Anna Aiello (Researcher under Law 240/10, type B, SSD MED/04 General Pathology, S.C. 06/A2; Assistant Professor of General Pathology., University of Palermo, Palermo, Sicily) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.